$0.9615
-0.00430-0.45%
In chiusura: -
$1.00
0.044.00%
After hour: Nov 7, 7:45 PM EDT
RenovoRx segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di RenovoRx utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
RNXT | RenovoRx | -$0.10 | -$0.08 | — | — | $0.00 | $346.40K | — | — | 11/13/2025 | |
RNXT | RenovoRx | -$0.10 | -$0.08 | -$0.08 | 0.00% | $0.00 | $288.35K | $422.00K | 46.35% | 08/14/2025 | |
RNXT | RenovoRx | -$0.07 | -$0.08 | -$0.08 | 0.00% | $0.00 | $183.33K | $197.00K | 7.46% | 05/15/2025 | |
RNXT | RenovoRx | -$0.30 | -$0.10 | -$0.12 | -20.00% | $0.00 | $167.50K | $43.00K | -74.33% | 03/31/2025 | |
RNXT | RenovoRx | -$0.13 | -$0.12 | -$0.10 | 16.67% | $0.00 | — | $0.00 | — | 11/13/2024 | |
RNXT | RenovoRx | -$0.22 | -$0.10 | -$0.10 | 0.00% | $0.00 | — | $0.00 | — | 08/13/2024 | |
RNXT | RenovoRx | -$0.36 | -$0.16 | -$0.07 | 56.25% | $0.00 | — | $0.00 | — | 05/10/2024 | |
RNXT | RenovoRx | -$0.23 | -$0.30 | -$0.30 | 0.00% | $0.00 | — | $0.00 | — | 04/01/2024 | |
RNXT | RenovoRx | -$0.24 | -$0.30 | -$0.13 | 56.67% | $0.00 | — | $0.00 | — | 11/14/2023 | |
RNXT | RenovoRx | -$0.29 | -$0.25 | -$0.22 | 12.00% | $0.00 | — | $0.00 | — | 08/17/2023 | |
RNXT | RenovoRx | -$0.33 | -$0.25 | -$0.36 | -44.00% | $0.00 | — | $0.00 | — | 05/15/2023 | |
RNXT | RenovoRx | -$0.12 | -$0.26 | -$0.23 | 11.54% | $0.00 | — | $0.00 | — | 03/02/2023 | |
RNXT | RenovoRx | -$0.27 | -$0.29 | -$0.24 | 17.24% | $0.00 | — | $0.00 | — | 11/14/2022 | |
RNXT | RenovoRx | -$0.57 | -$0.28 | -$0.29 | -3.57% | $0.00 | — | $0.00 | — | 08/15/2022 | |
RNXT | RenovoRx | -$0.51 | -$0.21 | -$0.33 | -57.14% | $0.00 | — | $0.00 | — | 05/13/2022 | |
RNXT | RenovoRx | -$0.41 | -$0.16 | -$0.12 | 25.00% | $0.00 | — | $0.00 | — | 03/30/2022 | |
RNXT | RenovoRx | -$0.48 | -$0.21 | -$0.27 | -28.57% | $0.00 | — | $0.00 | — | 11/15/2021 |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-0.08 | $-0.08 | 0.00 % |
| Q1 | 2025-05-15 | $-0.08 | $-0.08 | 0.00 % |
| Q4 | 2025-03-31 | $-0.12 | $-0.10 | -20.0 % |
| Q3 | 2024-11-13 | $-0.10 | $-0.12 | 16.7 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $422.00K | $288.35K | 46.4 % |
| Q1 | 2025-05-15 | $197.00K | $183.33K | 7.46 % |
| Q4 | 2025-03-31 | $43.00K | $167.50K | -74.3 % |
Si prevede che RenovoRx (RNXT) fornisca risultati il novembre 13, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.08, che centrato la stima di $-0.08.
Le entrate effettive sono state $422K, che superato la stima di $288.4K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.